SITE-DIRECTED MUTAGENESIS OF GLYCOSYLATION SITES IN THE TRANSFORMING GROWTH FACTOR-BETA-1 (TGF-BETA-1) AND TGF-BETA-2 (414) PRECURSORS AND OF CYSTEINE RESIDUES WITHIN MATURE TGF-BETA-1 - EFFECTS ON SECRETION AND BIOACTIVITY

被引:63
|
作者
BRUNNER, AM [1 ]
LIOUBIN, MN [1 ]
MARQUARDT, H [1 ]
MALACKO, AR [1 ]
WANG, WC [1 ]
SHAPIRO, RA [1 ]
NEUBAUER, M [1 ]
COOK, J [1 ]
MADISEN, L [1 ]
PURCHIO, AF [1 ]
机构
[1] BRISTOL MYERS SQUIBB PHARMACEUT RES INST, 3005 1ST AVE, SEATTLE, WA 98121 USA
关键词
D O I
10.1210/me.6.10.1691
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The transforming growth factor-beta1 (TGFbeta1) and -beta2 (414) precursors both contain three predicted sites of N-linked glycosylation within their pro regions. These are located at amino acid residues 72, 140, and 241 for the TGFbeta2 (414) precursor and at residues 82, 136, and 176 for the TGFbeta1 precursor; both proteins contain mannose-6-phosphate (M-6-P) residues. The major sites of M-6-P addition are at Asn (82) and Asn (136), the first two sites of glycosylation, for the TGFbeta1 precursor. We now show that the major site of M-6-P addition within the TGFbeta2 (414) precursor is at Asn241, the third glycosylation site. To determine the importance of N-linked glycosylation to the secretion of TGFbeta1 and -beta2, site-directed mutagenesis was used to change the Asn residues to Ser residues; the resulting DNAs were transfected into COS cells, and their supernatants were assayed for TGFbeta activity. Substitution of Asn (241) of the TGFbeta2 (414) precursor resulted in an 82% decrease in secreted TGFbeta2 bioactivity. Mutation at Asn72 resulted in a 44% decrease, while mutation at Asn140 was without effect. Elimination of all three glycosylation sites resulted in undetectable levels of TGFbeta2. These results were compared with similar mutations made in the cDNA encoding the TGFbeta1 precursor. Mutagenesis of the two M-6-P-containing sites (Asn82 and Asn136) resulted in an 83% decrease in secreted TGFbeta1; replacement of Asn82 and Asn136 with Ser individually resulted in 85% and 42% decreases in activity, respectively. Substitution of Asn176 with Ser was without effect, while substitution of all three sites of glycosylation resulted in undetectable levels of TGFbeta1 activity, similar to the results obtained with TGFbeta2. The nine Cys residues within the mature region of TGFbeta1 were mutated to serine, and their effects on TGFbeta1 secretion were evaluated. Mutation of most Cys residues resulted in undetectable levels of TGFbeta1 protein or activity in conditioned medium. Mutation of Cys (355) led to the secretion of inactive TGFbeta1 monomers, suggesting that this residue is either directly involved in dimer formation or required for correct interchain disulfide bond formation.
引用
收藏
页码:1691 / 1700
页数:10
相关论文
共 50 条
  • [21] IMMUNOHISTOCHEMICAL ANALYSIS OF TGF-BETA-1 AND TGF-BETA-2 AND TGF-BETA-RESPONSIVE CELLS IN HYPERTROPHIC SCARS AND KELOIDS
    KSANDER, G
    GERHARDT, C
    HIGLEY, H
    PORRASREYES, B
    MUSTOE, T
    CLINICAL RESEARCH, 1992, 40 (01): : A46 - A46
  • [22] THE LIVER IN TRANSFORMING GROWTH-FACTOR-BETA-1 (TGF-BETA-1) NULI MICE
    WILLIAMS, AO
    KNAPTON, AD
    GEISER, AG
    LETTERIO, JJ
    ROBERTS, AB
    GASTROENTEROLOGY, 1995, 108 (04) : A1016 - A1016
  • [23] NEUROPROTECTIVE EFFECTS OF TGF-BETA-1
    HENRICHNOACK, P
    PREHN, JHM
    KRIEGLSTEIN, J
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1994, (43): : 33 - 45
  • [24] EFFECTS OF RETINOIDS ON COLLAGEN AND TRANSFORMING GROWTH FACTOR-BETA-1 (TGF-BETA-1) GENE-EXPRESSION IN ITO CELLS
    SHAH, A
    WEINER, FR
    HEPATOLOGY, 1989, 10 (04) : 630 - 630
  • [25] TRANSFORMING GROWTH FACTOR-BETA-1 (TGF-BETA-1) INCREASES THE SYNTHESIS OF UROKINASE PLASMINOGEN-ACTIVATOR BY MONOCYTES
    MIRSHAHI, M
    NELLES, L
    SORIA, J
    LIJNEN, HR
    SORIA, C
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 880 - 880
  • [26] DIFFERENTIAL EXPRESSION OF TRANSFORMING GROWTH FACTOR-BETA-1 (TGF-BETA-1) RECEPTORS IN MURINE MYELOID CELL-LINES TRANSFORMED WITH ONCOGENES - CORRELATION WITH DIFFERENTIAL GROWTH-INHIBITION BY TGF-BETA-1
    BIRCHENALLROBERTS, MC
    FALK, LA
    KASPER, J
    KELLER, J
    FALTYNEK, CR
    RUSCETTI, FW
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (15) : 9617 - 9621
  • [27] ENHANCED SECRETION OF ACTIVATED TGF-BETA-1 AND POSTRECEPTOR BLOCKADE TO TGF-BETA-1 SIGNALING IN HIGHLY MALIGNANT FIBROSARCOMAS
    SCHWARZ, LC
    WRIGHT, JA
    HALL, A
    PIMENTEL, M
    CHAN, A
    SPORN, M
    GREENBERG, AH
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1990, 593 : 315 - 317
  • [28] EFFECTS OF TRANSFORMING GROWTH FACTOR-BETA-1 (TGF-BETA-1) ON ITO CELL EXTRACELLULAR-MATRIX GENE-EXPRESSION
    WEINER, FR
    SHAH, A
    CZAJA, MJ
    GIAMBRONE, MA
    ZERN, MA
    HEPATOLOGY, 1989, 10 (04) : 682 - 682
  • [29] INDUCTION OF TRANSFORMING GROWTH FACTOR-BETA-1 (TGF-BETA-1) RECEPTOR EXPRESSION AND TGF-BETA-1 PROTEIN-PRODUCTION IN RETINOIC ACID-TREATED HL-60 CELLS - POSSIBLE TGF-BETA-1-MEDIATED AUTOCRINE INHIBITION
    FALK, LA
    DEBENEDETTI, F
    LOHREY, N
    BIRCHENALLROBERTS, MC
    ELLINGSWORTH, LW
    FALTYNEK, CR
    RUSCETTI, FW
    BLOOD, 1991, 77 (06) : 1248 - 1255
  • [30] INCREASED TRANSFORMING GROWTH FACTOR-BETA-1 (TGF-BETA-1) GENE-EXPRESSION IN HUMAN-LIVER DISEASE
    ANNONI, G
    CZAJA, MJ
    WEINER, FR
    ZERN, MA
    HEPATOLOGY, 1988, 8 (05) : 1227 - 1227